Treatment of Gram-negative bacterial infections with antimicrobial agents can cause release of the endotoxin (lipopolysaccharide, LPS), the potent initiator of sepsis, which is the major cause of mortality in intensive care units worldwide. Structural information on peptides bound to LPS can lead the development of more effective endotoxin neutralizers. Short linear antimicrobial and endotoxin-neutralizing peptide LF11, based on the human lactoferrin binds to LPS, inducing a peptide fold with "T-shape" arrangement of hydrophobic core and two clusters of basic residues that match the distance between the two phosphate groups of LPS. Side chain arrangement of LF11 bound to LPS extends the previously proposed LPSbinding pattern, emphasizing the importance of both electrostatic and hydrophobic interactions in a defined geometric arrangement. In anionic micelles the LF11 forms amphipathic conformation with smaller hydrophobic core than in LPS, while in zwitterionic micelles the structure is even less defined. Protection of tryptophan fluorescence quenching in the order SDS>LPS>DPC and hydrogen exchange protection indicates the decreasing extent of insertion of the Nterminus and potential role of peptide plasticity in differentiation between bacterial and eukaryotic membranes.
Bacterial lipopolysaccharide (LPS) is one of the most potent inducers of the innate immune response. In contrast to adaptive immune system, innate immunity engaging "pattern recognition receptors" recognizes the conserved motif of molecules characteristic for the pathogens. Pathogen associated molecular patterns (PAMPs), rather than highly variable strainspecific molecules allow recognition and response to the broad range of pathogens. Recognition of various forms of LPS from different strains of Gram-negative bacteria, where the lipid A moiety represents the PAMP triggers the signaling cascade, resulting in release of proinflammatory mediators such as cytokines as well as small molecules such as lipid mediators, reactive oxygen species etc (1) . In advanced stages of sepsis, when the immune response is over stimulated and deregulated, the pathological consequences are so diverse, ranging from hypotension to intravascular coagulation and multiple organ failure, that treatment of a single target such as for example TNFα is insufficient. Sepsis claims each year more than 200,000 lives in the USA alone. Mortality of patients with sepsis is still above 30% and higher in the elderly (2) , in large extent due to the lack of the effective treatment of the underlying pathology. The preferable treatment at early stages of sepsis or prevention in case of high risk of sepsis might combine the antimicrobial activity to destroy bacteria with neutralization of endotoxin to prevent its interaction with serum and cellular receptors such as LBP, CD14 and the MD2/TLR4 complex (3), which directly recognize endotoxin and initiate the immune response. The small cyclic lipopeptide polymyxin B (PmxB) is the prototype peptide capable of neutralizing LPS (4) . Due to its nephrotoxic and neurotoxic effect its application is limited to topical use. Structural information on the interaction of peptides and receptor proteins with LPS is required for the improved design of antiendotoxic drugs. Due to the heterogeneity of LPS and its aggregational properties (5) structural studies of LPS have rarely been successful. The only precise structural information of LPS interacting with a protein originates from the crystal structure of the E.coli iron uptake receptor protein, FhuA, which is an integral membrane protein and has been fortuitously crystallized in complex with an LPS molecule (6) . Based on this complex a 3D structural pattern has been proposed consisting of the geometric arrangement of cationic side chains, to which many of the proteins known to interact with LPS adhere (7) . The structure of PmxB in its LPS-bound conformation has been 2 determined (8) using the transferred NOE (TRNOE) (9) . The TRNOE occurs in case of weak binding of a smaller ligand (in this case: peptide) to a large molecule or assembly (in this case: LPS aggregate or micelle); the crossrelaxation in the bound species is much larger than in the free ligand and is transferred to the latter through chemical exchange. The intramolecular NOEs of the bound ligand therefore occur at the resonance frequencies of the free ligand and allow the determination of the boundstate conformation of the peptide from the intramolecular NOE interactions between ligand protons. Accurate peptide structures can be determined with relatively few NOE interactions when the interactions occur between nonneighboring residues (10) . Lactoferrin, an iron binding glycoprotein, and its N-terminal peptide fragments neutralize LPS and have antimicrobial activity (11;12) . The Nterminal segment of lactoferrin adopted the α-helical conformation in integral lactoferrin, while the cleaved 25 residue peptide, stabilized by a disulfide bridge, folded into a hairpin structure (13) . A six-residue (RRWQWR) peptide fragment with the sequence of bovine lactoferrin was shown to form a structured cluster of aromatic side-chains in SDS micelles (14) . However, attempts to determine the structure of lactoferricin or any other LPS-neutralizing peptide of eukaryotic origin in complex with LPS have not been successful. In order to identify the structural pattern of LPSbinding and selectivity for disrupting the bacterial membranes we have determined the solution structure of LF11, an 11-residue peptide based on human lactoferrin that can neutralize LPS and has antimicrobial activity against Gramnegative as well as Gram-positive bacteria (15;16) . Solution NMR structures of LF11 were determined in complex with LPS using the TRNOE and in anionic (SDS) and zwitterionic (DPC) micelles. Each lipid environment leads to the conformational adaptation of the peptide from a disordered structure in solution, governed by the constraints imposed by each type of environment. Differences in lipid composition between the bacterial and eukaryotic membrane allows the specificity of membrane active antimicrobial peptides. Those particular structural requirements on the peptide can be used for the design of more potent endotoxinneutralizing agents, while the adaptation of the peptide for interaction with anionic lipids is important for understanding the antimicrobial activity.
MATERIALS AND METHODS
Peptide preparation -The peptide LF11 (FQWQRNIRKVR-NH2) was synthesized by the W.M. Keck facility at Yale University using the Fmoc (N-(9-fluorenyl)methoxycarbonyl)) method. Peptide was purified using HPLC and verified by mass spectroscopy. Fluorescence spectroscopy-The intrinsic peptide fluorescence was measured in a luminescence spectrometer LS55 (Perkin-Elmer) at 25°C in a quartz cuvette of 1 cm path length. Excitation wavelength was 280 nm, and excitation and emission slit widths 5 nm. 
Nuclear
Magnetic Resonance (NMR) Spectroscopy-The sample of free LF11 was prepared by dissolving lyophilized peptide in 20 mM sodium phosphate buffer, pH 5.5 and 8% of D 2 O. The final peptide concentration was 2 mM. LF11 with LPS was prepared by adding 25µL of 10 mg/mL LPS (Escherichia coli serotype 055:B5) stock solution to 1.5 mg of LF11. The ratio between peptide and LPS was 20:1. Samples with LF11 in micellar environment were prepared at 200 mM SDS-d25 and 240 mM DPC-d38 obtaining thus an excess of micelle concentration relative to the peptide, assuming that 62 molecules of SDS and 54 molecules of DPC form an SDS and DPC micelle, respectively. The pH was adjusted to 5.5. Spectra were recorded at 30°C on a Varian Unity INOVA 600 MHz spectrometer equipped with zgradients and a triple resonance probe. 2-D homonuclear TOCSY and NOESY spectra were acquired with 2048×512 data points and spectral widths of 8000 Hz in both dimensions with 48 to 64 transients. TOCSY spectra were recorded at mixing times of 10 (for COSY-type information) and 70-100 ms. NOESY spectra were recorded at mixing times of 80 and 150 ms. Water suppression was achieved using WET (17) or WATERGATE (18) . NMR data were processed using Felix 2000.1 (Accelrys). Resolution enhancement was achieved by apodization of the free induction decay with a shifted square sinebell window function. Chemical shifts were referenced to the internal standard 4,4-dimethyl-4-silapentane-1-sulfonate (DSS). Semi-automatic NOE assignment with calibration of volumes and conversion of volumes into DYANA restraints for upper bounds was achieved using the inhouse program nmr2st (19) . The presence of NOE intensities from the free peptide was taken into account by reducing the weight given to intraresidual and sequential peaks observed in the reference spectrum of LF11 in the absence of LPS or micelles. Two well resolved geminal methylene proton cross-peaks of N6 and W3 were used for calibration. The experimental distance constraints were then employed to generate peptide conformers using 6000 steps of simulated annealing in torsion angle space implemented in the program DYANA version 1.5 (20) . 10-20 structures with the lowest target function out of 100 calculated structures were kept for further minimization. DISCOVER (Accelrys) using the cvff force field (21) was used to energy minimize the structures. The quality of structures was checked with PROCHECK_NMR (22) . Structures were visualized and analyzed with INSIGHTII (Accelrys) and MOLMOL (23) . For H-D exchange experiments lyophilized peptide was dissolved in D 2 O solution of perdeurated SDS [DPC] in 20 mM phosphate buffer and 1D spectra were measured at time points up to 360 minutes. 5-doxyl stearic acid (5-DSA) was used as a paramagnetic probe to examine depth of insertion of the peptide in SDS and DPC micelles. Stock solution of DSA in deuterated methanol was added to 2 mM concentration and pH was adjusted to 5.35 -5.5. Intensities of H N -H α cross peaks in 2D NOESY spectra (mixing time of 80 ms) were measured. The relative cross peak height (RA) was evaluated as a ratio of cross peak heights in the presence and absence of the paramagnetic reagent, normalized so that the least affected cross peak had the amplitude of 100%. Dissociation rate constant was determined using CPMG-T2 experiment with presaturation for water suppression (24) on LF11 samples with added LPS at the LPS/peptide molar ratios of 1/10 and 1/30. Spectra were recorded at d2 delays of 50, 100, 200, 400, 800, 1600 and 3200 µs. Shifted square sine-bell window function was used for apodization. Peak intensities had strictly exponential decay under all peptide/lipopolysaccharide ratios. Relaxation rates were fitted to the equation:
where Peptide docking to LPS-The coordinates of the lipid A portion of LPS from 1QFF 7 (including two KDO residues) and the bound conformations of LF11 obtained from NMR refinement were used for molecular docking calculations with the program AutoDock (25) . The peptide backbone was kept rigid while all side-chains were defined as flexible using the deftors module; lipid A was treated as the macromolecule part of the docking calculation and was therefore kept rigid. The AutoGrid calculation was run with 100 points (separated by .325 Å) in each spatial dimension, with the grid centered at the H2 atom of the GlcN II residue of the lipid A moiety. The AutoDock calculation was run using the Lamarckian Genetic Algorithm using a translation step (tstep) of 0.2 Å, a quaternion step (qstep) of 5.0 deg and a torsion step (tstep) of 5.0 deg. In the analysis step ten of the generated docked structures were evaluated.
RESULTS
Structure of LF11 bound to bacterial lipopolysaccharide LF11 has antimicrobial activity against Gramnegative and Gram-positive bacteria (26) , binds to the LPS and is able to neutralize the biological activity of LPS in the in vitro LAL (limulus amoebocyte lysate) test and in monocytes (27) . LF11 does not form any detectable persistent tertiary structure in solution, as indicated by the absence of long range NOEs in 2D NOESY or ROESY spectra ( Fig. 1.a) . Addition of equimolar amounts of LPS to the millimolar concentration of the peptide caused precipitation of the LPSpeptide aggregates, preventing determination of the structure in the 1:1 complex. Addition of LPS to the peptide at a molar ratio of 1:20 resulted in an increase of intensity and appearance of additional NOE cross peaks in the 2D NOESY spectra due to the TRNOE (Fig. 1.b) . The latter appears because of the rapid exchange between the LPS-bound and free form of LF11 at acidic pH. CPMG-T2 relaxation experiments were used to obtain the dissociation rate constant k off , resulting in values of 1988 s -1 and 1635 s -1 for peptide/LPS ratios of 10/1 and 30/1, respectively (data not shown). LF11 in complex with LPS forms a well defined conformation with a backbone r.m.s.d. of 1.3 Å for the residues 2-10 ( Fig. 2) . The structural definition decreases from the N-towards the C Docking of the peptide to LPS suggests that the two phosphate groups of the lipid A moiety are positioned close to the guanidino groups of Arg5 and Arg11, respectively, with the separation between the two cationic clusters of approx. 13 Å, matching the distance between the phosphate groups of the lipid A moiety. Several of the cationic groups in the second cluster (Arg8, Lys9, Arg11) are able to interact favorably with the phosphate group of the lipid A moiety. The guanidino group of Arg8 may also interact with carboxyl groups of the KDO (2-keto-3-deoxyoctonate) sugar units which are conserved in the LPS forms of Gram-negative bacteria (Fig.  3) . The Trp3 ring is positioned at the interface between the aliphatic chains and polar groups of the LPS layer, while the Phe1 side-chain is positioned close to the aliphatic side chains approximately at the level of the third carbon methylene group. Addition of lipoteichoic acid (LTA) to LF11 also induced a number of TRNOE cross peaks, indicating that the peptide binds to LTA as well. LTA is a component of the Gram-positive bacterial cell wall and is a weaker stimulant of the immune system than LPS, acting through the TLR2 receptors (28) . However, in contrast to LPS addition of LTA did not result in a compact structure of LF11, as indicated by the absence of long-and medium-range NOEs; the bound peptide structure therefore did not converge in the model building.
Structure of LF11 in SDS and DPC micelles
LF11 bound to added SDS and DPC micelles as indicated by a large decrease of T 2 value, corresponding to increased correlation time. In SDS micelles LF11 folds into a well-defined loop with backbone atom r.m.s.d. of the ensemble of 1.7 Å. The hydrophobic peptide core is packed in a similar arrangement as in complex with LPS, involving Trp3 sandwiched between Phe1 and Ile7 (according to NOEs between Phe1/Trp3 and Trp3/Ile7, respectively) while Val10 does not show any non-trivial NOEs and obviously does not participate in the hydrophobic core. The structural definition is enhanced by NOEs between Trp3-Hε1 and the main chain (HN and HA) of Arg5. The four basic residues are grouped on top of the molecule with their charged side-chains resembling the ribs of an umbrella, with the hydrophobic N-terminus forming its handle (Fig. 4) . In DPC micelles the structure of LF11 is less defined than in the former two cases; it preserves the hydrophobic core of the Phe1, Trp3 and Ile7; however, the arrangement of their side-chains is less linear. Trp3 interacts with Phe1 and Ile7 but not with Val10, as in SDS micelles; however, the contact between residues 3 and 5 is missing. Local r.m.s.d. of LPS and SDS structures displays lower values at positions of hydrophobic residues Phe1, Trp3, Ile7 and also Val10 and higher at hydrophilic loops. Particularly Ile7 is less flexible in LPS in comparison to SDS structure, since it interacts with Val10 in the former structure. In DPC structure the average displacement is lower at Gln2, Ile6 and also Val10 but higher at Trp3 in comparison to the SDS structure. Fig. 5 ). Protection from solvent in SDS is extended to Arg5, according to the chemical shift of its HN that is downfield shifted to 7.18 ppm (compared to 8.04 in DPC micelles). Arg5-HN is oriented towards the hydrophobic core, as indicated also by its NOE contact with Trp3-Hε1. In SDS micelles the amide group of Gln2 could be observed in the hydrogen-exchange experiment for more than 2 hours (exchange constant 0.029 ± 0.001 min -1 , data not shown) and is therefore protected from hydrogen exchange in contrast to DPC, where complete hydrogen exchange occurred within the dead time of our hydrogen exchange experiment (few minutes). Further characterization of positioning in micelles was determined by the paramagnetic line-broadening reagent 5-doxyl-stearic acid, appropriate for the shallow burial of a short peptide, with a paramagnetic group is at position 5, where is expected to be close to the level of phosphate groups of phospholipids (29) . In both SDS and DPC micelles the intraresidual cross peaks showed differential line broadening upon addition of 5-DSA. In SDS the lowest line broadening occurred at positions Arg5, Val10 and Arg11 and the highest at positions Gln2 and Asn6 (Phe1 HN is not observable). This suggests penetration into the upper region of the lipid layer by the N-terminus of the peptide and exposure of the C-terminal residues. In DPC Arg5 and Lys9 are the least affected, while the largest decrease is observed at Gln2 and Asn6, also indicating the interaction of the hydrophobic N-terminus with the lipid interior.
Localization of the peptide in micelles

DISCUSSION
Structural conservation of the LPS-binding motif
Structural investigation of the antimicrobial and endotoxin-neutralizing peptide LF11 in different amphiphillic environment was aimed at understanding the structural basis of neutralization of LPS and differentiation between bacterial and eukaryotic membranes. We have compared the structure of the LF11-LPS complex with the FhuA-LPS complex (PDB code 1QFF), the only determined protein structure with bound LPS, where the membrane protein FhuA interacts with LPS via the sidechains of residues from three antiparallel beta strands (6) . Despite completely different backbone fold the side-chains of LF11 interacting with LPS correspond quite well to those of FhuA when the LPS molecules of both complexes are superimposed (Fig. 6) , i.e. Arg5 of LF11 corresponds to Lys439 of FhuA, Lys9 to Lys351, Arg11 to Lys351 and Phe1 to Phe355, respectively, with side-chain r.m.s.d. of 2.8 Å. The structural LPS binding motif based on the complex between FhuA and LPS has been previously proposed, comprising four basic residues (Lys306, Lys351, Arg382 and Lys439 of FhuA) in a defined geometric arrangement, allowing for Lys/Arg replacements(7). This proposed motif was limited to electrostatic interactions involving polar head group of LPS, particularly the pair of phosphates, and neglects the interaction with hydrophobic residues that participate in recognition and biological activity of LPS. Indeed fatty acid chains are essential for biological activity of LPS and the number and type of acyl chains significantly affect the recognition and ensuing biological activity of LPS (30) . In the FhuA-LPS structure a layer of hydrophobic residues next to the layer of cationic residues interacts with fatty acid chains of LPS. The above mentioned spatial fit of Phe1 of LF11 to Phe355 in FhuA indicates that hydrophobic residues are in fact conserved and should be included in the improved definition of the structural LPS binding motif (31) . Arg382 of FhuA corresponds to Trp3 of LF11. Tryptophan residue of membrane active proteins and peptides frequently interact with phospholipids at the level of carbonyl groups (32) . Trp3 of LF11 is unique in having a dual role of interacting with LPS and at the same time serving as the key residue to organize the peptide fold by interacting with other hydrophobic residues. Polypeptide fold of PmxB is restricted by cyclization and in larger proteins by the packing of secondary structure elements. Side chains of LF11 interacting with LPS also correspond well to residues PmxB bound to LPS, with Phe1 of LF11 and Phe6 in PmxB interacting with the acyl chains of LPS, and with Arg5 of LF11 and corresponding to Dab (α,γ-diaminobutyric acid) residues 8 and 9 of PmxB, while Lys9 and Arg11 of LF11 correspond to Dab1 and Dab5 of PmxB, respectively (Fig. 6) . The LF11 structure therefore supports the notion that the LPS-recognition motif encompasses the arrangement of both cationic and hydrophobic binding sites.
Interaction of peptide with anionic and zwitterionic micelles and comparison with folds of other membrane-active antimicrobial peptides
Cationic antimicrobial peptides are thought to exert their antimicrobial activity on the bacterial inner membrane, which in contrast to eukaryotic membranes contains a high fraction of anionic lipids such as phosphatidylglycerol or cardiolipin (33) (34) (35) (36) . Short antimicrobial peptides in amphipathic environment predominantly fold into α-helical (e.g. magainin, CAP18 106-137 (37)), β-hairpin (e.g. protegrin, tachyplesin (38) ) or extended (V-type) conformation (e.g. indolicidin, tritrpticin (39)) (Fig. 7) or are constrained into a defined conformation by backbone cyclization or disulfide crosslinks (e.g. polymyxins, defensins (40)). Longer peptides can form transmembrane pores while the proposed mechanism of membrane disruption by shorter peptides is initiated by peptide association with the outer membrane layer, its translocation across the outer membrane by the self-promoted peptide uptake and formation of defects in the bacterial cytoplasmic membrane (41) . The LF11 peptide is too short to cross the bilayer; it can, however, destabilize the bacterial membrane, as observed by permeabilizing bacterial cells to hydrophobic probes, such as NPN (data not shown) and its action on artificial membranes composed of anionic lipids (42) . Linear cationic peptides without secondary structure, such as tryptophan-rich antimicrobial peptides (tritrpticin, indolicidin) (6) (43) (44) (45) and also the bovine variant of the lactoferrin peptide fragment, conform to the sequence pattern BHB of central hydrophobic (H: mainly tryptophan) residues flanked by cationic residues (denoted B) on both sides of the peptide. The studied human lactoferrin peptide, on the other hand, exhibits the pattern HBHB, where upon its interaction with anionic amphiphilles the hydrophobic core is formed, composed of nonconsecutive hydrophobic residues. This results in the sequestration of positively charged and hydrophobic residues into separate regions of the molecule. LPS forms a planar face composed of 6-7 saturated acyl chains, which results in a large complementary nonpolar surface of the peptide (Fig 3) . As a result, the bound LF11 folds into a T-shaped planar conformation with the central hydrophobic core along the vertical line of the "T" attaching to the nonpolar surface of LPS and the two hydrophilic clusters at the tips of the horizontal line targeting the two phosphate groups of the lipid A moiety. Val10 is part of the hydrophobic core and, with its orientation towards Phe1 and Trp3, enables Arg11, along with Arg8 and Lys9, to become part of the second hydrophilic cluster. In SDS, which contains only a single charge per molecule the peptide adopts a similar conformation as upon interaction with LPS but is less planar with the hydrophobic N-terminus penetrating into the lipid interior of the micelles and the basic residues forming electrostatic interactions with the negatively charged groups at the surface of the micelle. Val10 is no longer part of the hydrophobic core and the two separated hydrophilic clusters are lost. Such a model of membrane-inserted N-terminus and surfaceoriented C-terminus is also in agreement with line broadening experiments. Cardiolipin, representing significant fraction of bacterial cell membrane lipids, particularly in Gram-positive bacteria (33), represents with its two separated negatively charged centers the likely target which might stabilize the peptide structure into the similarly defined conformation as upon the interaction with LPS. This could be the reason for comparable antimicrobial activity of LF11 and its derivatives against Gram-negative and positive bacteria. LF11 in DPC micelles forms a less defined structure due to its reduced interaction with zwitterionic amphiphilles and insertion into the membrane. Peptide plasticity can enhance the selectivity between the eukaryotic and bacterial membranes. LF11 exhibits significant adaptation to different type of environment, folding into the defined amphipathic conformation upon interaction with anionic lipids. Differences between the anionic and zwitterionic membranes could be further exploited for design of antimicrobial peptides. It has been reported that in some peptides the structure is conserved in both types of the micellar environment (e.g. in indolicidin the differences between the SDS and DPC-bound structure were very small), while it is significantly different in other cases (46;47) . An example of peptide adaptation upon binding to bacterial ligand has been shown for the lantibiotic mersacidin, which specifically binds to a peptidoglycans precursor (48) . The appropriate range of peptide chain size is probably a decisive factor for conformational plasticity of peptides; a long peptide chain may have strong propensity for a defined secondary structure, imposing a barrier to structural transition imposed by the lipid environment, while short peptides may not be able to form a defined tertiary structure with a stabilizing core. In integral lactoferrin the peptide corresponding to LF11 forms part of the α-helix and its disulfide connected lactoferricin fragment forms a hairpin (49) . Extreme structural adaptation of a peptide as described in this report therefore emphasizes the importance of determining its tertiary structure in different environments and inadequacy of relying on the structure of the peptide fragment in different structural context. 
